Systematic analysis of telomere length and somatic alterations in 31 cancer types

Cited by (615)

Items 201–300 of 615

1. High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer
   Simon Garinet, G. Pignot, Sophie Vacher, Constance Le Goux, Anne Schnitzler, Walid Chemlali, Nanor Sirab, Nicolas Barry Delongchamps, Marc Zerbib, Mathilde Sibony et al. · 2018 · Molecular Cancer Research
2. The Role of Alternative RNA Splicing in the Regulation of hTERT, Telomerase, and Telomeres: Implications for Cancer Therapeutics
   Aaron L. Slusher, Jeongjin Kim, Andrew T. Ludlow · 2020 · Cancers
3. Shelterin complex gene: Prognosis and therapeutic vulnerability in cancer
   Vikas Kumar Bhari, Durgesh Kumar, Surendra Kumar, Rajeev Mishra · 2021 · Biochemistry and Biophysics Reports
4. Decoding human cancer with whole genome sequencing: a review of PCAWG Project studies published in February 2020
   Simona Giunta · 2021 · Cancer and Metastasis Reviews
5. High prevalence of TERT aberrations in myxoid liposarcoma: TERT reactivation may play a crucial role in tumorigenesis
   Junko Kunieda, Kyoko Yamashita, Yuki Togashi, Satoko Baba, Seiji Sakata, Kentaro Inamura, Keisuke Ae, Seiichi Matsumoto, Rikuo Machinami, Masanobu Kitagawa et al. · 2021 · Cancer Science
6. Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenance
   Fei Li, Yizhe Wang, Inah Hwang, Ja-Young Jang, Libo Xu, Zhong Deng, Eun Young Yu, Yiming Cai, Caizhi Wu, Zhenbo Han et al. · 2023 · Nature Communications
7. What telomeres teach us about MS
   Annalise E. Miner, Jennifer Graves · 2021 · Multiple Sclerosis and Related Disorders
8. The telomere length landscape of prostate cancer
   Julie M. Livingstone, Yu-Jia Shiah, Takafumi N. Yamaguchi, Lawrence E. Heisler, Vincent Huang, Robert Lesurf, Tsumugi Gebo, Benjamin Carlin, Stefan E. Eng, Erik Drysdale et al. · 2021 · Nature Communications
9. Prognostic implication of TERT promoter mutation and circulating tumor cells in muscle-invasive bladder cancer
   Raquel Carrasco, Mercedes Ingelmo‐Torres, Ascensión Gómez, Fiorella L. Roldán, Natalia Segura, María José Ribal, Antonio Alcaraz, Laura Izquierdo, Lourdes Mengual · 2022 · World Journal of Urology
10. Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer
    Carter J. Barger, Abigail Kora Suwala, Katarzyna M. Soczek, Albert Wang, Min Y. Kim, Chibo Hong, Jennifer A. Doudna, Susan Marina Chang, Joanna J. Phillips, David A. Solomon et al. · 2022 · Nature Communications
11. Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
    David Esopi, Mindy Kim Graham, Jacqueline A. Brosnan‐Cashman, Jennifer L. Meyers, Ajay M. Vaghasia, Anuj Kumar Gupta, Balasubramanian Kumar, Michael C. Haffner, Christopher M. Heaphy, Angelo Michael De Marzo et al. · 2020 · Cellular Oncology
12. Cytokinesis-block micronucleus cytome (CBMN-CYT) assay biomarkers and telomere length analysis in relation to inorganic elements in individuals exposed to welding fumes
    Milton Quintana-Sosa, Grethel León-Mejía, Jaime Luna-Carrascal, Yurina Sh De Moya, Ibeth Luna Rodríguez, Antonio J. Acosta-Hoyos, Marco Anaya-Romero, Cristiano Trindade, Diana M. Narváez, Helena Groot et al. · 2021 · Ecotoxicology and Environmental Safety
13. TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors
    Božo Krušlin, Zoran Gatalica, Ondřej Hes, Faruk Skenderi, Markku Miettinen, Elma Contreras, Joanne Xiu, Michelle Ellis, Elena Florento, Semir Vranić et al. · 2021 · Clinical Genitourinary Cancer
14. Pan-Cancer Analysis of Clinical Relevance via Telomere Maintenance Mechanism
    Ji‐Yong Sung, Jae‐Ho Cheong · 2021 · International Journal of Molecular Sciences
15. The telomere maintenance mechanism spectrum and its dynamics in gliomas
    Sojin Kim, Tamrin Chowdhury, Hyeon Jong Yu, Jee Ye Kahng, Chae Eun Lee, Seung Ah Choi, Kyung‐Min Kim, Ho Jung Kang, Joo Ho Lee, Soon‐Tae Lee et al. · 2022 · Genome Medicine
16. Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers
    Cristina Montero‐Conde, Luis Javier Leandro-Garcia, Ángel M. Martínez‐Montes, Paula Martínez, Francisco Moya, Rocío Letón, Eduardo Gil, Natalia Martínez‐Puente, Sonsoles Guadalix, María Currás-Freixes et al. · 2022 · Clinical and Translational Medicine
17. Reliable assessment of telomere maintenance mechanisms in neuroblastoma
    Alina Meeser, Christoph Bartenhagen, Lisa Werr, Anna‐Maria Hellmann, Yvonne Kahlert, Nadine Hemstedt, Peter Nürnberg, Janine Altmüller, Sandra Ackermann, Barbara Hero et al. · 2022 · Cell & Bioscience
18. TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance
    Tiantian Liu, Shihong Li, Chuanyou Xia, Dawei Xu · 2023 · Frontiers in Immunology
19. Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients
    Sehui Kim, Chung Lee, Hyangmi Kim, Sun Och Yoon · 2023 · Oral Oncology
20. Genome rearrangements associated with aberrant telomere maintenance
    Ragini Bhargava, Matthias Fischer, Roderick J. O’Sullivan · 2020 · Current Opinion in Genetics & Development
21. A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches
    Mina Iskandar, Miguel Xiao Barbero, Mohammed Tariq Jaber, Roy Chen, Romulo Gomez-Guevara, Edwin Cruz, Sandy D. Westerheide · 2025 · Cancers
22. The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas
    POLA network, Nathalie Grandin, Bruno Pereira, Camille Cohen, Pauline Billard, Caroline Dehais, Catherine Carpentier, Ahmed Idbaïh, Franck Bielle, François Ducray et al. · 2019 · Acta Neuropathologica Communications
23. Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers
    Yongxing Wu, Liang Shi, Yuelei Zhao, Pu Chen, Rongrong Cui, Meiju Ji, Nongyue He, Maode Wang, Gang Li, Peng Hou · 2021 · npj Precision Oncology
24. Integrated evaluation of telomerase activation and telomere maintenance across cancer cell lines
    Kevin Hu, Mahmoud Ghandi, Franklin W. Huang · 2021 · eLife
25. Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants
    Jennifer L. Stundon, Heba Ijaz, Krutika Satish Gaonkar, Rebecca Kaufman, Run Jin, Anastasios Karras, Zalman Vaksman, Jung Kim, Ryan J. Corbett, Matthew R. Lueder et al. · 2022 · Neuro-Oncology
26. The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes
    Radhia M’kacher, Corina Cuceu, Mustafa Al Jawhari, Luc Morat, Monika Frenzel, Grace Shim, Aude Lenain, William M. Hempel, Steffen Junker, T. Girinsky et al. · 2018 · Cancers
27. Telomere-related prognostic biomarkers for survival assessments in pancreatic cancer
    Shengyang Chen, Shuiquan Hu, Zhou Baizhong, Bingbing Cheng, Hao Tong, Dongchao Su, Xiaoyong Li, Yan-Jun Chen, Genhao Zhang · 2023 · Scientific Reports
28. Cell-based chemical fingerprinting identifies telomeres and lamin A as modifiers of DNA damage response in cancer cells
    Chiaki Fujiwara, Yukiko Muramatsu, Megumi Nishii, Kazuhiro Tokunaka, Hidetoshi Tahara, Masaru Ueno, Takao Yamori, Yoshikazu Sugimoto, Hiroyuki Seimiya · 2018 · Scientific Reports
29. ARID1A‐SIN3A drives retinoic acid‐induced neuroblastoma differentiation by transcriptional repression of TERT
    Chi‐Bao Bui, Hoa Kim Le, Diem My Vu, Kieu‐Diem Dinh Truong, Nhat Manh Nguyen, Minh Anh Nguyen Ho, Dinh Quang Truong · 2019 · Molecular Carcinogenesis
30. Chemical targeting of G-quadruplexes in telomeres and beyond for molecular cancer therapeutics
    Hiroyuki Seimiya, Kazuo Nagasawa, Kazuo Shin‐ya · 2021 · The Journal of Antibiotics
31. Neuroblastoma—Telomere maintenance, deregulated signaling transduction and beyond
    Sabine A. Stainczyk, Frank Westermann · 2021 · International Journal of Cancer
32. Genomic footprints of activated telomere maintenance mechanisms in cancer
    Lina Sieverling, Chen Hong, Sandra D. Koser, Philip Ginsbach, Kortine Kleinheinz, Barbara Hutter, Delia M. Braun, Isidro Cortés‐Ciriano, Ruibin Xi, Rolf Kabbe et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
33. Integrated Analysis of Nine Prognostic RNA-Binding Proteins in Soft Tissue Sarcoma
    Lulu Lin, Zizhen Liu, Jingzhuo Tian, Xiao Zhang, Yan Zhang, Min Yang, Hou-Cheng Zhong, Wei Fang, Renxiong Wei, Chao Hu · 2021 · Frontiers in Oncology
34. TElomeric repeat-containing RNA (TERRA): Physiological functions and relevance in cancer
    Michal Kroupa, Kristýna Tomášová, Miriam Kavec, Pavel Škrobánek, Tomáš Büchler, Rajiv Kumar, Ľudmila Vodičková, Pavel Vodička · 2022 · Frontiers in Oncology
35. DNA and RNA Binding Proteins: From Motifs to Roles in Cancer
    Ondřej Bonczek, Lixiao Wang, Sivakumar Vadivel Gnanasundram, Sa Chen, Lucia Hároníková, Filip Zavadil Kokas, Bořivoj Vojtěšek · 2022 · International Journal of Molecular Sciences
36. Thyroid carcinoma‐featured telomerase activation and telomere maintenance: Biology and translational/clinical significance
    Xiaotian Yuan, Huiyang Yuan, Ning Zhang, Tiantian Liu, Dawei Xu · 2022 · Clinical and Translational Medicine
37. Advances in adrenal tumors 2018
    Joakim Crona, Felix Beuschlein, Karel Pacák, Britt M. Skogseid · 2018 · Endocrine Related Cancer
38. Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E
    Young Shin Song, Young Joo Park · 2020 · Endocrinology and Metabolism
39. Impacts of chromatin dynamics and compartmentalization on DNA repair
    Takaaki Yasuhara, Lee Zou · 2021 · DNA repair
40. Distinct telomere length and molecular signatures in seminoma and non-seminoma of testicular germ cell tumor
    Hua Sun, Pora Kim, Peilin Jia, Ae Kyung Park, Han Liang, Zhongming Zhao · 2018 · Briefings in Bioinformatics
41. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis
    Nisha Subhashchandra Ramani, Phyu P. Aung, Jun Gu, Steven M. Sfamenos, Chiara Sdringola-Maranga, Priyadharsini Nagarajan, Michael T. Tetzlaff, Jonathan L. Curry, Doina S. Ivan, Adi K. Diab et al. · 2020 · Modern Pathology
42. Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review)
    Yang Liu, Na Li, Meng Wang, Zhang Yan-hua, Lu-Da Yan, Wen Zhou, Zhi-Qiong Yu, Xiaochun Peng, Jun Cai · 2021 · Oncology Reports
43. Extra-telomeric impact of telomeres: Emerging molecular connections in pluripotency or stemness
    Soujanya Vinayagamurthy, Akansha Ganguly, Shantanu Chowdhury · 2020 · Journal of Biological Chemistry
44. Prognostic significance of TERT promoter mutations in adult-type diffuse gliomas
    Hideyuki Arita, Koichi Ichimura · 2022 · Brain Tumor Pathology
45. Telomere alterations in neurofibromatosis type 1-associated solid tumors
    Fausto J. Rodríguez, Mindy Kim Graham, Jacqueline A. Brosnan‐Cashman, John R. Barber, Christine Davis, M. Adelita Vizcaíno, Doreen N. Palsgrove, Caterina Giannini, Melike Pekmezci, Sonika M Dahiya et al. · 2019 · Acta Neuropathologica Communications
46. Human Endometrial Carcinogenesis Is Associated with Significant Reduction in Long Non-Coding RNA, TERRA
    Meera Adishesh, Rafah Alnafakh, Duncan M. Baird, Rhiannon E. Jones, Shannon Simon, Lucy Button, Areege Mustafa Kamal, John Kirwan, S.B. Decruze, Josephine A. Drury et al. · 2020 · International Journal of Molecular Sciences
47. Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer
    Hajar El Ahanidi, Meryem El Azzouzi, Chaimae Hafidi Alaoui, M. Tetou, Mounia Bensaid, Imane Chaoui, Laïla Benbacer, Ilias Hassan, Mohamed Oukabli, Katarzyna Michaud et al. · 2022 · Frontiers in Oncology
48. Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis
    Kirill E. Medvedev, Anna Savelyeva, Kenneth Sung-Man Chen, Aditya Bagrodia, Liwei Jia, Nick V. Grishin · 2022 · Cancer Informatics
49. Neotelomeres and telomere-spanning chromosomal arm fusions in cancer genomes revealed by long-read sequencing
    Kar‐Tong Tan, Michael K. Slevin, Mitchell L. Leibowitz, Max Garrity-Janger, Jidong Shan, Heng Li, Matthew M. Meyerson · 2024 · Cell Genomics
50. Genetic regulation of TERT splicing affects cancer risk by altering cellular longevity and replicative potential
    Oscar Flórez-Vargas, Michelle Ho, Maxwell H. Hogshead, Brenen W. Papenberg, Chia‐Han Lee, Kaitlin Forsythe, Kristine M. Jones, Wen Luo, Kedest Teshome, Cornelis Blauwendraat et al. · 2025 · Nature Communications
51. Modeling Genomic Instability and Selection Pressure in a Mouse Model of Melanoma
    Lawrence N. Kwong, Lihua Zou, Sharmeen Chagani, Chandra Sekhar Pedamallu, Mingguang Liu, Shan Jiang, Alexei I. Protopopov, Jianhua Zhang, Gad A. Getz, Lynda Chin · 2017 · Cell Reports
52. Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors
    Tomas Goncalves, Georgia Zoumpoulidou, Carlos Alvarez-Mendoza, Caterina Mancusi, Laura C. Collopy, Sandra J. Strauss, Sibylle Mittnacht, Kazunori Tomita · 2020 · ACS Pharmacology & Translational Science
53. Low Protein Expression of both ATRX and ZNRF3 as Novel Negative Prognostic Markers of Adult Adrenocortical Carcinoma
    Vania Balderrama-Brondani, Amanda Meneses Ferreira Lacombe, Beatriz M. P. Mariani, Luciana Ribeiro Montenegro, Iberê Cauduro Soares, João Evangelista Bezerra Neto, Fábio Y Tanno, Victor Srougi, Jose Luis Chambo, Berenice Bilharinho Mendonca et al. · 2021 · International Journal of Molecular Sciences
54. How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?
    Jesmin Akter, Takehiko Kamijo · 2021 · Biomolecules
55. Relative Telomere Length Change in Colorectal Carcinoma and Its Association with Tumor Characteristics, Gene Expression and Microsatellite Instability
    Muhammad Ghulam Kibriya, Maruf Raza, Mohammed Kamal, Zahidul Haq, Rupash Paul, Andrew Mareczko, Brandon L. Pierce, Habibul Ahsan, Farzana Jasmine · 2022 · Cancers
56. Genomic, epigenomic, and transcriptomic signatures for telomerase complex components: a pan‐cancer analysis
    Jing Wang, Mingkai Dai, Xiangling Xing, Xing Wang, Xin Qin, Tao Huang, Zhiqing Fang, Yidong Fan, Dawei Xu · 2022 · Molecular Oncology
57. Decoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis
    Moisés Selman, Ivette Buendia-Roldan, Annie Pardo · 2025 · European Respiratory Journal
58. Connecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells
    Eun Young Yu, Nai‐Kong V. Cheung, Neal F. Lue · 2022 · Journal of Hematology & Oncology
59. Telomeres are shorter in wild Saccharomyces cerevisiae isolates than in domesticated ones
    Melania D’Angiolo, Jia‐Xing Yue, Matteo De Chiara, Benjamin P. Barré, Marie-Josèphe E. Giraud-Panis, Éric Gilson, Gianni Liti · 2022 · Genetics
60. The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia
    Tales Henrique Andrade da Mota, Ricardo Camargo, Estefânia Rodrigues Biojone, Ana Flávia Reis Guimarães, Fabio Pittella-Silva, Diêgo Madureira de Oliveira · 2023 · Genes
61. Molecular Mechanism of Telomere Length Dynamics and Its Prognostic Value in Pediatric Cancers
    Zhaoming Wang, Stephen V. Rice, Ti‐Cheng Chang, Yu Liu, Qi Liu, Na Qin, Daniel K. Putnam, Kyla Shelton, Jennifer Q. Lanctot, Carmen Louise Wilson et al. · 2019 · JNCI Journal of the National Cancer Institute
62. Telomerase reverse transcriptase promoter mutations in thyroid carcinomas: implications in precision oncology—a narrative review
    Xiaotian Yuan, Tiantian Liu, Dawei Xu · 2020 · Annals of Translational Medicine
63. Telomerase reverse transcriptase promoter mutation– and O6-methylguanine DNA methyltransferase promoter methylation–mediated sensitivity to temozolomide in isocitrate dehydrogenase–wild-type glioblastoma: is there a link?
    Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, Marietta Wolter, Gabriele Schackert, Manfred Westphal, Luca Regli, Niklas Thon, Marcos Soares Tatagiba, Wolfgang Wick et al. · 2021 · European Journal of Cancer
64. PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power
    Alexandra Maria Poos, Cornelia Schroeder, Neeraja Jaishankar, Daniela Röll, Marcus Oswald, Jan Meiners, Delia M. Braun, Caroline Knotz, Lukas Frank, Manuel Gunkel et al. · 2022 · Cancers
65. Therapeutic Vulnerability to ATR Inhibition in Concurrent NF1 and ATRX-Deficient/ALT-Positive High-Grade Solid Tumors
    Ming Yuan, C. Eberhart, C. Pratilas, J. Blakeley, Christine Davis, Marija Stojanova, Karlyne M. Reilly, A. Meeker, C. Heaphy, F. Rodriguez · 2022 · Cancers
66. CRISPR/Cas technologies in pancreatic cancer research and therapeutics: recent advances and future outlook
    Hanieh Noormohamadi, Hamed Soleimani Samarkhazan, Maryam Kargar, Faezeh Maroufi, Nazli Servatian, Fatemeh Davami · 2025 · Discover Oncology
67. The epigenetic dysfunction underlying malignant glioma pathogenesis
    Sharvari Dharmaiah, Jason T. Huse · 2022 · Laboratory Investigation
68. The ALT pathway generates telomere fusions that can be detected in the blood of cancer patients
    Francesc Muyas, Manuel J. Gómez, Rita Cascão, Ângela Afonso, Carolin M. Sauer, Cláudia C. Faria, Isidro Cortés‐Ciriano, Ignacio Flores · 2024 · Nature Communications
69. Alternative Lengthening of Telomeres and Chromatin Status
    Ion Udroiu, Antonella Sgura · 2019 · Genes
70. Telomere attrition and dysfunction: a potential trigger of the progeroid phenotype in nijmegen breakage syndrome
    Raneem Habib, Ryong Kim, Heidemarie Neitzel, Ilja Demuth, Krystyńa Chrzańowska, E Seemanová, R Faber, Martin Digweed, Reinhard Voß, Kathrin Jäger et al. · 2020 · Aging
71. qmotif: determination of telomere content from whole-genome sequence data
    Oliver Holmes, Kátia Nones, Yue Tang, Kelly A. Loffler, Michael Lee, Ann‐Marie Patch, Rebecca A. Dagg, Loretta M. S. Lau, Conrad Leonard, Scott Wood et al. · 2022 · Bioinformatics Advances
72. Telomere Maintenance in Pediatric Cancer
    Sandra Ackermann, Matthias Fischer · 2019 · International Journal of Molecular Sciences
73. Present and Future of Anti-Glioblastoma Therapies: A Deep Look into Molecular Dependencies/Features
    Hyeon Ji Kim, Do‐Yeon Kim · 2020 · Molecules
74. G‐quadruplex‐forming nucleic acids interact with splicing factor 3B subunit 2 and suppress innate immune gene expression
    Kyoko Matsumoto, Keiji Okamoto, Sachiko Okabe, Risa Fujii, Koji Ueda, Kenichi Ohashi, Hiroyuki Seimiya · 2020 · Genes to Cells
75. REIA: A database for cancer A-to-I RNA editing with interactive analysis
    Huimin Zhu, Lu Huang, Songbin Liu, Zhiming Dai, Zhou Songyang, Zhihui Weng, Yuanyan Xiong · 2022 · International Journal of Biological Sciences
76. Digital CRISPR/Cas12a-based platform for precise quantification of telomerase activity
    Xinyi Luo, Yunzhu Wan, Ke Wang, Qidong Wei, Ziming Yu, Lei Chen, 周建华, Jiasi Wang · 2023 · Sensors and Actuators B Chemical
77. Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers
    Elizabeth Córdoba-Lanús, Luis M. Montuenga, Angélica Domínguez-de-Barros, Alexis Oliva, Delia Mayato, Ana Remírez-Sanz, Francisca Gonzalvo, Bartolomé R. Celli, Javier J. Zulueta, Ciro Casanova · 2024 · Antioxidants
78. The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines
    Antonia D’Aniello, Alessandra Del Bene, Salvatore Mottola, Vincenzo Mazzarella, Roberto Cutolo, Erica Campagna, Salvatore Di Maro, Anna Messere · 2024 · Journal of Peptide Science
79. Attenuation of ATM signaling by ROS delays replicative senescence at physiological oxygen
    Alexander Stuart, Kaori Takai, Railia R Gabbasova, Henry Sanford, Ekaterina V. Vinogradova, Titia de Lange · 2025 · Molecular Cell
80. Benchmarking: contexts and details matter
    Siyuan Zheng · 2017 · Genome biology
81. ETS variant transcription factor 5 and c-Myc cooperate in derepressing the human telomerase gene promoter via composite ETS/E-box motifs
    Fan Zhang, Shuwen Wang, Jiyue Zhu · 2020 · Journal of Biological Chemistry
82. Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches
    Shirley Chu, Zachary L. Skidmore, Jason Kunisaki, Jason Walker, Malachi Griffith, Obi L. Griffith, Jeffrey N. Bryan · 2021 · PLoS ONE
83. Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus
    Danielle Perez-Bercoff, Hélène Laude, Morgane Lemaire, Oliver E. Hunewald, Valérie Thiers, Marco Vignuzzi, Hervé Blanc, Aurélie Poli, Zahir Amoura, Vincent Caval et al. · 2021 · Scientific Reports
84. When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM
    Saumya Bollam, Michael E. Berens, Harshil Dhruv · 2018 · Current Neurology and Neuroscience Reports
85. Telomerase reverse transcriptase promoter mutations in hepatocellular carcinogenesis
    Zi-Xian Ma, Chunmei Yang, Mengge Li, Hong Tu · 2019 · Hepatoma Research
86. Regulatory grammar in human promoters uncovered by MPRA-based deep learning
    Lucía Barbadilla-Martínez, Noud H.M. Klaassen, Vinícius H. Franceschini-Santos, Jérémie Breda, Hatice Yücel, Miguel Hernández-Quiles, Tijs van Lieshout, Carlos G. Urzúa-Traslaviña, Minh Chau Luong Boi, Maryam Akbarzadeh et al. · 2026 · Nature
87. Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer
    Qingrong Li, Qiang Ma, Lei Xu, Chuanli Gao, Lihua Yao, Jilin Wen, Miyuan Yang, Jibing Cheng, Xi Zhou, Jiang Zou et al. · 2021 · Frontiers in Pharmacology
88. Prognostic value and immune landscapes of TERT promoter methylation in triple negative breast cancer
    Fei Lin, Jiajia Huang, Wancui Zhu, Tongchao Jiang, Jia Guo, Wen Xia, Miao Chen, Ling Guo, Wuguo Deng, Huan‐Xin Lin · 2023 · Frontiers in Immunology
89. Genome maintenance meets mechanobiology
    Vincent Spegg, Matthias Altmeyer · 2023 · Chromosoma
90. TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer
    Shiyong Li, Guanghui Hu, Yulu Chen, Ye Sang, Qin Tang, Rengyun Liu · 2024 · Cancer Cell International
91. TERT Alterations in Progressive Treatment-Resistant Meningiomas
    Tareq Adnan Juratli, Priscilla Kaliopi Brastianos, Daniel P. Cahill · 2018 · Neurosurgery
92. Hepatitis B Virus Integration into Transcriptionally Active Loci and HBV-Associated Hepatocellular Carcinoma
    Maria Bousali, Timokratis Karamitros · 2022 · Microorganisms
93. Heterogeneity of telomerase reverse transcriptase mutation and expression, telomerase activity and telomere length across human cancer cell lines cultured in vitro
    Marta Dratwa, Barbara Wysoczańska, Eliza Turlej, Artur Anisiewicz, Magdalena Maciejewska, Joanna Wietrzyk, Katarzyna Bogunia‐Kubik · 2020 · Experimental Cell Research
94. TERT Promoter Mutations Increase Sense and Antisense Transcription from the TERT Promoter
    François Hafezi, Lisa Jaxel, Morgane Lemaire, Jonathan D. Turner, Danielle Perez-Bercoff · 2021 · Biomedicines
95. Multi-omics and single cell characterization of cancer immunosenescence landscape
    Qiuxia Wei, Ruizhi Chen, Xuedan He, Yanan Qu, Changjian Yan, Xiaoni Liu, Jing Liu, Jiahao Luo, Zining Yu, Wenping Hu et al. · 2024 · Scientific Data
96. Telomere Maintenance and DNA Repair: A Bidirectional Relationship in Cancer Biology and Therapy
    Nina Rembiałkowska, Mikołaj Sędzik, Monika Kisielewska, Wiktoria Łuniewska, Kamil Sebastianka, Klaudia Molik, Katarzyna Skinderowicz, Jacek Kuźnicki, Joanna Tunikowska, Julita Kulbacka · 2025 · Cancers
97. Alternative Lengthening of Telomeres (ALT) and Telomerase Reverse Transcriptase Promoter Methylation in Recurrent Adult and Primary Pediatric Pituitary Neuroendocrine Tumors
    Hiba Alzoubi, Simone Minasi, Francesca Gianno, Manila Antonelli, Francesca Belardinilli, Felice Giangaspero, Marie‐Lise Jaffrain‐Rea, Francesca Romana Buttarelli · 2022 · Endocrine Pathology
98. The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset
    Renan Brito Gadelha, Caio Bezerra Machado, Flávia Melo Cunha de Pinho Pessoa, Laudreísa da Costa Pantoja, Igor Valentim Barreto, Rodrigo Monteiro Ribeiro, Manoel Odorico de Moraes, Maria Elisabete Amaral de Moraes, André Salim Khayat, Caroline Aquino Moreira-Nunes · 2022 · Current Issues in Molecular Biology
99. Research progress of small-molecule drugs in targeting telomerase in human cancer and aging.
    Ziyi Shen, Yuan-Hui Wang, Guanzheng Wang, Weijie Gu, Sheng-Chao Zhao, Xiao-Meng Hu, W. Liu, Yi Cai, Zhihong Ma, R. Gautam et al. · 2023 · Chemico-Biological Interactions
100. The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target?
     Vincenzo Di Nunno, Marta Aprile, Stefania Bartolini, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Dario de Biase, Sofia Asioli, Enrico Franceschi · 2023 · Cells